Literature DB >> 30181935

Assessment of the impact of an exercise program on the physical and functional capacity in patients with autosomal recessive spastic ataxia of Charlevoix-Saguenay: An exploratory study.

Olivier Audet1, Hung Tien Bui2, Maxime Allisse3, Alain-Steve Comtois4, Mario Leone3.   

Abstract

Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a neuromuscular disorder caused by the mutation of the SACS gene. Clinical symptoms of this disease include progressive ataxia, spasticity, and peripheral neuropathy. Similar to other neuromuscular disorders, these patients are prone to physical deconditioning which may lead to a loss of functional capacity. This paper aims to evaluate the impact of a training program on the physical fitness and the functional capacity of ARSACS patients. Twelve patients (age: 28.1 ± 8.2 years) participated in this study. They followed an eight-week training program including physical activities, strength-power and aerobic training. Compared to the initial evaluation, measures of physical fitness and functional capacity were significantly improved (p ≤ 0.05) for 11 of the 12 tests. Positive gains were also observed for fall frequency and for upper-limb incoordination. This paper supports the importance of a training program for ARSACS patients in order to improve their quality of life. Through these types of interventions, it may be possible to slow down the progression of the disease and help maintain functional capacity.

Entities:  

Keywords:  ARSACS; Ataxia; exercise training; functional capacity; upper-limb incoordination

Year:  2018        PMID: 30181935      PMCID: PMC6119673          DOI: 10.5582/irdr.2018.01060

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  35 in total

Review 1.  Exercise in neuromuscular disease.

Authors:  Yaacov Anziska; Alex Sternberg
Journal:  Muscle Nerve       Date:  2013-05-22       Impact factor: 3.217

Review 2.  Rehabilitation techniques to maximize spasticity management.

Authors:  Lynne Romeiser Logan
Journal:  Top Stroke Rehabil       Date:  2011 May-Jun       Impact factor: 2.119

Review 3.  Strength training and aerobic exercise training for muscle disease.

Authors:  Nicoline B M Voet; Elly L van der Kooi; Ingrid I Riphagen; Eline Lindeman; Baziel G M van Engelen; Alexander C H Geurts
Journal:  Cochrane Database Syst Rev       Date:  2013-07-09

4.  Autosomal recessive spastic ataxia of Charlevoix-Saguenay.

Authors:  Yoshihisa Takiyama
Journal:  Neuropathology       Date:  2006-08       Impact factor: 1.906

5.  Exercise in neuromuscular disease.

Authors:  Lisa S Krivickas
Journal:  J Clin Neuromuscul Dis       Date:  2003-09

6.  The multicomponent nature of equilibrium in persons with parkinsonism: a regression approach.

Authors:  T Toole; S Park; M A Hirsch; D A Lehman; C G Maitland
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 7.  Locomotor activity in spinal cord-injured persons.

Authors:  V Dietz; Susan J Harkema
Journal:  J Appl Physiol (1985)       Date:  2004-05

8.  Autosomal recessive spastic ataxia of Charlevoix-Saguenay.

Authors:  J P Bouchard; A Barbeau; R Bouchard; R W Bouchard
Journal:  Can J Neurol Sci       Date:  1978-02       Impact factor: 2.104

9.  Strength training versus robot-assisted gait training after incomplete spinal cord injury: a randomized pilot study in patients depending on walking assistance.

Authors:  Rob Labruyère; Hubertus J A van Hedel
Journal:  J Neuroeng Rehabil       Date:  2014-01-09       Impact factor: 4.262

10.  A best practice fall prevention exercise program to improve balance, strength / power, and psychosocial health in older adults: study protocol for a randomized controlled trial.

Authors:  Yves J Gschwind; Reto W Kressig; Andre Lacroix; Thomas Muehlbauer; Barbara Pfenninger; Urs Granacher
Journal:  BMC Geriatr       Date:  2013-10-09       Impact factor: 3.921

View more
  1 in total

Review 1.  Genetics of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) and Role of Sacsin in Neurodegeneration.

Authors:  Jaya Bagaria; Eva Bagyinszky; Seong Soo A An
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.